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Background: Lichen planus (LP) is a chronic inflammatory, immunological, mucocutaneous disease can affect 
skin, genital and oral mucosa. Oral lichen planus (OLP) is the most common noninfectious, chronic inflammatory 
oral disease affecting 1-2% of the general adult population. World Health Organization (WHO) classifies OLP 
as a potentially malignant disorder. Epstein Barr virus or human herpesvirus-4, is a member of the herpes virus 
family and one of the most ubiquitous viruses known to human, infecting approximately 90% of the world’s adult 
population. The virus often infects B lymphocytes resulting in a wide spectrum of mucocutaneous and systemic 
diseases, ranging from mild lesions to aggressive malignancies. The aim of this study was to investigate expres-
sion of the EBV encoded RNAs EBER1 and EBER2 in oral and genital lichen planus and compare results with 
normal tissues in situ hybridization which is considered the golden standard for detection of EBER.
Material and Methods: A total of 68 biopsies, 25 oral LP, 26 genital LP, 10 oral controls and finally 7 genital con-
trols were analysed using situ hybridization.
Result: All samples had RNA as shown by the control slide, whereas no case contained neither EBER1 nor EBER2.
Conclusions: Based on results from our study EBV is not involved in aetiology of lichen planus. 




Lichen planus (LP) is a chronic inflammatory, immuno-
logical, mucocutaneous disease with different clinical 
appearances (1,2). LP can affect skin, genital and oral 
mucosa, scalp and nails (3). Oral lichen planus (OLP) is 
the most common noninfectious, chronic inflammatory 
disease affecting 1-2% of the general adult population 
(4) but the range of prevalence varies among differ-
ent populations in the world (3). The disease is more 
common among women than men and most often oc-
curs in middle-aged patients (3)The oral mucosa can be 
the only site of involvement (1).  However, in a recently 
published paper it has been shown that the vast major-
ity of patients have multifocal lesions (5). LP has been 
characterised as a T-cell mediated and autoimmune 
disease, whereas the exact trigger mechanisms of LP 
development are not yet fully understood (6). As with 
LP, the aetiology of OLP is not yet fully understood (3), 
but autoimmunity could be a causative or contributing 
factor to OLP (7,8).  It has been shown that LP may be 
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associated with other autoimmune diseases, such as ul-
cerative colitis, vitiligo and myasthenia gravis (4). OLP 
lesions can affect any mucosal surface in oral cavity 
but the most common affected locations are the buccal 
mucosa. The clinical expression varies between six dif-
ferent variants: papular, plaque-like, bullous, atrophic, 
reticular and erosive (2). Histologically OLP is charac-
terized by a band like massive infiltrate of lymphocytes 
in the superficial lamina propia. It is also characterized 
by hyperkeratosis, degeneration of basal cell layer and 
possibly saw tooth appearance or absence of rete ridges 
(2). In contrast to dermal LP, mucosal LP is considered 
to follow a more chronic direction and therefore has 
only a small chance for spontaneous regression (9).
World Health Organization (WHO) classifies OLP as a 
potentially malignant disorder (2). The malignant po-
tential of OLP, however, is highly controversial (9, 10). 
Former studies have shown that OLP can develop into 
squamous cell carcinoma (SCC) but the exact carcino-
genetic mechanism is still not discovered.
EBV or human herpesvirus-4, is a member of herpes 
virus family and one of the most ubiquitous viruses 
known to human, infecting approximately 90% of the 
world’s adult population.  Like all herpes viruses EBV 
may remain in the host organism for life, but in most 
cases does not cause any harm in healthy carriers (11). 
The virus often infects B lymphocytes resulting in a 
wide spectrum of mucocutaneous and systemic dis-
eases, ranging from mild lesions to aggressive malig-
nancies (12). The virus only affects humans and two 
types have been identified: Type A or 1 and type B or 2. 
Epstein-Barr virus can either be in a latent phase within 
memory B cells or in a lytic, active phase responsible 
for viral replication (12).
Primary EBV infection occurring in children is often 
asymptomatic (13). In contrast, primary EBV infection 
in older patients causes infectious mononucleosis (IM) 
in 30% to 50% of infected persons (14). In recent years 
possible viral infection such as Hepatitis C virus, Hu-
man Herpes virus-6 and EBV has been linked to aetiol-
ogy of OLP (15). 
Epstein Barr virus encoded RNA can be detected by 
different methods but Epstein Barr virus-encoded RNA 
in situ hybridization is considered the gold standard for 
detecting and localizing latent Epstein Barr virus in tis-
sue samples (16,17). The aim of this study was to in-
vestigate expression of the EBV encoded RNAs EBER1 
and EBER2 in oral and genital lichen planus and com-
pare results with normal tissues using golden standard 
of in situ hybridization. 
Material and Methods
A total of 68 biopsies were collected in this study. These 
biopsies consisted of 25 oral LP, 26 genital LP, 10 oral 
controls (OC) and finally 7 genital controls (GC) (Ta-
ble 1). All 51 samples of LP were in an active state of 
inflammation, showing a well-defined inflammatory 
infiltrate. None of the OLP biopsies had histologically 
dysplastic features. 
Samples, were retrieved from the archives at the De-
partment of Clinical Pathology, University Hospital, 
Umeå. The study was approved by the Ethical Review 
Board at Umeå University (dnr 2013-252-32M). 
For EBER-in situ hybridisation (EBER-ISH) a commer-
cially available kit was used. From each samples two 
sections were cut and in one of the sections EBER1 and 
EBER 2 was detected using the Inform EBER Probe 
(800-2842, Ventana Medical Systems, Roche Diagnos-
tics GmbH, Mannheim Germany). At the same time 
section number 2 was incubated with an RNA Positive 
Control Probe (800-2846, Ventana) in order to make 
sure mRNA was present in the samples. The NBT-BCIP 
Detection Chemistries (800-092, Roche Diagnostics 
GmbH, Mannheim, Germany) was used for detection. 
Stainings were performed using a Bench Mark Ultra 
(Ventana Medical Systems, Inc, Tucson, AZ, USA) ac-
cording to the supplier’s protocols. 
 
Results
All biopsies were assessed by to investigators (ME and 
KD) independently. In cases of disagreement slides 
were discussed in a joint session until consensuses was 
reached. 
All samples had RNA as shown by the control slide, 
whereas no case contained neither EBER1 nor EBER2 
(Fig. 1). 
Oral LP
Male        Female
Genital LP
Male          Female
OC
Male      Female
GC
Male      Female
Number 8 17 7 19 7 3 0 7
Range year 73-21 81-36 73-32 84-39 27-58 46-59 60-78
Mean age 52 62.5 50.5 58 39 53 67.5
Table 1. Data on patients and controls regarding gender and age
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Discussion
Since the discovery of the EBV, the first identified hu-
man tumour virus by Epstein (Epstein et al., 1964) this 
virus has been the subject of study in many kinds of 
cancer. The virus often infects B lymphocytes result-
ing in a wide spectrum of mucocutaneous and systemic 
diseases, ranging from mild lesions to aggressive ma-
lignancies (12).
EBV is one of the most ubiquitous viruses known to hu-
man infecting approximately 90% of the world’s adult 
population.  Like all herpes viruses EBV may remain 
in the host organism for life, but in most cases it does 
not cause any harm in healthy carriers (11). The oral 
cavity is a primary site for transmission and persistence 
of EBV.  EBV can also be detected in other anatomi-
cal sites, and is found in blood circulating B cells in 
healthy carriers (18). In order to study presence of EBV 
one must target the specific tissue or organ with specific 
method.
EBER represent two RNA species, EBER1 and EBER2, 
encoded from two separate but homologous viral genes. 
EBER transcripts are expressed in latently infected 
cells at levels approaching a million copies per cell (19). 
Because EBER transcripts are naturally amplified, they 
represent a reliable target for detecting and localizing 
EBV in tissue sections by in situ hybridization (20). 
This may explain why our results differ from the previ-
ous study. 
Reviewing literatures reveals rather few papers with 
divergent results depending on different method and 
choice of tissue. In this study in contrary to all other 
studies we could not detect occurrence of EBER expres-
sion in epithelium in oral and genital lichen planus as 
well as healthy controls. Yildirim and co-workers used 
immunohistochemistry, staining OLP slides with EBV 
primary antibody EBV/LMP-Ab-1 and found that 35% 
of OLP patients were positive and suggested that EBV 
may play a role in the ethiopathogenesis of OLP 
By using PCR or ELISA some investigators detect an-
tibodies against EBV in approximately 25% of LP pa-
tients (21-23) while others have found as high as 62% 
EBV positive tissue, 18%  in saliva, 17% in exfoliated 
cells and 8% of plasma , using nested PCR (24). Still, no 
correlation between OLP and EBV was seen.
Using different PCR techniques, requires initial homog-
enizing of tissue and extraction of DNA. This elimi-
nates the possibility of determining which cell type 
harboured the virus, and allows for false positive results 
Fig. 1. Representative slides from OLP and control. Slides a) OLP and C) control show occurrence of RNA 
whereas b) OLP and d) control contained neither EBER1 nor EBER2.
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due to contamination with laboratory EBV DNA or 
EBV-infected lymphocytes in the specimen.  The posi-
tive result for EBV by solution PCR could have been 
due to EBV-infected lymphocytes rather than LP epi-
thelium.
Despite intense research in the field of lichen planus 
there are some crucial questions that remain unan-
swered among those premalignant potential of lichen 
planus and some authors investigate expression of EBV 
in lichen planus and somehow connect it to LP ś pre- 
malignant potential. 
Results of our study is based on Epstein Barr virus-
encoded RNA in situ hybridization which is considered 
the golden standard for detecting and localizing latent 
Epstein Barr virus in tissue samples (16,17). 
EBER transcripts are systematically expressed in every 
EBV-infected tumour, and in lymphoid tissues taken 
from patients with infectious mononucleosis, and in the 
rare infected cell representing normal flora in healthy 
virus carriers.  In fact, oral hairy leukoplakia is the only 
EBV-related lesion that lacks EBER (25).
Based on results from our study EBV is not involved in 
aetiology of lichen planus. 
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